IP Library Granted Patent US 9,220,799
Granted Patent B2
US 9,220,799 · App. 14/708,631 · Granted Dec 29, 2015

Bactericidal agent composition

Inventors: Miwa Ishii (Osaka, JP); Toru Oka (Osaka, JP); Yoshimitsu Nakayama (Osaka, JP); Masumi Torii (Osaka, JP); Masaru Sugimori (Osaka, JP); Shogo Takashiba (Okayama, JP); Hiroshi Maeda (Okayama, JP); Fumi Mineshiba (Okayama, JP); Kimito Hirai (Okayama, JP)
Assignees: SUNSTAR ENGINEERING INC.; NATIONAL UNIVERSITY CORPORATION OKAYAMA UNIVERSITY; SUNSTAR INC.
A61L2/18A01N25/00A01N25/02A01N25/34A01N43/36A01N59/12A01N65/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,220,799
App. No.
14/708,631
Granted
Dec 29, 2015
Kind
B2
Abstract

[Problem] To provide: a bactericidal agent composition which can exhibit an excellent bactericidal effect in the presence of an organic substance and against biofilms; a method for producing the bactericidal agent composition; and a sterilization method using the bactericidal agent composition. [Solution] A bactericidal agent composition which comprises water containing ultrafine bubbles having a most frequent particle diameter of 500 nm or less and a bactericidal component. Preferably, the density of most frequent particles of the ultrafine bubbles are 10,000 particles or more and the density of ultrafine bubbles each having a particle diameter of 1000 nm or less is 1,000,000 particles or more.

Claims (5)

1. A method of sterilization comprising a step in which a bactericidal agent composition comprising ultrafine bubbles having a most frequent particle diameter of 500 nm or less and a bactericidal component is brought into contact with a biofilm,

wherein the bactericidal component is selected from the group consisting of: chloroisocyanuric acid, nonoxynol iodine, phenoxy iodine, potassium permanganate, glutaraldehyde, phtharal, formaldehyde, parachloromethacresol, parachlorometaxylenol, ortho phenylphenol, alkyl esters of paraoxybenzoic acid, hexachlorophene, mercury (II) chloride, thimerosal, benzethonium chloride, dequalinium chloride, N-lauryldiaminoethylglycine, N-myristyldiethylglycine, N-alkyl-N-carboxymethylammonium betaine, 2-alkyl-1-hydroxyethyl imidazoline betaine sodium, Hinokitiol, cassia oil, Chenopodiaceae oil, geraniol, saflol, polylysine, lysozyme, histatin, defensins, lactoferrin and lactoferricin.

2. The method according to claim 1 , wherein a density of most frequent particles among the ultrafine bubbles is 1×10 4 particles or more.

3. The method according to claim 1 , wherein a density of ultrafine bubbles each having a particle diameter of 1000 nm or less is 1×10 6 or more.

4. The method according to claim 1 , wherein an interior of the ultrafine bubbles is filled with one or more gases selected from the group consisting of air, oxygen, hydrogen, nitrogen, carbon dioxide, argon, neon, xenon, a fluorinated gas, ozone, and an inert gas.

Priority Claims (1)
JP 2012-043932 · Feb 29, 2012 · national
Continuity (2)
Division 14377315
Related Publication 20150258232A1 · Sep 17, 2015